Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma.
source https://www.sciencedaily.com/releases/2021/08/210806104354.htm
Saturday, 7 August 2021
Related Posts
Researchers harvest energy from radio waves to power wearable devices
Cholesterol may be key to new therapies for Alzheimer's disease, diabetes
Ocean currents predicted on Saturn's moon Enceladus
California's diesel emissions rules reduce air pollution, protect vulnerable communities
Fast-acting, color-changing molecular probe senses when a material is about to fail
Turning wood into plastic
0 comments: